Mechanism of substrate recognition by botulinum neurotoxin serotype A

被引:71
作者
Chen, Sheng
Kim, Jung-Ja P.
Barbieri, Joseph T. [1 ]
机构
[1] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
关键词
D O I
10.1074/jbc.M611211200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Botulinum neurotoxins (BoNTs) are zinc proteases that cleave SNARE proteins to elicit flaccid paralysis by inhibiting neurotransmitter-carrying vesicle fusion to the plasma membrane of peripheral neurons. Unlike other zinc proteases, BoNTs recognize extended regions of SNAP25 for cleavage; however, the molecular basis for this extended substrate recognition is unclear. Here, we define a multistep mechanism for recognition and cleavage of SNAP25 by BoNT/A. SNAP25 initially binds along the belt region of BoNT/A, which aligns the P5 residue to the S5 pocket at the periphery of the active site. Although the exact order of each step of recognition of SNAP25 by BoNT/A at the active site is not clear, the initial binding could subsequently orient the P4'-residue of SNAP25 to form a salt bridge with the S4'-residue, which opens the active site allowing the P1'-residue access to the S1'-pocket. Subsequent hydrophobic interactions between the P3 residue of SNAP25 and the S3 pocket optimize alignment of the scissile bond for cleavage. This explains how the BoNTs recognize and cleave specific coiled SNARE substrates and provides insight into the development of inhibitors to prevent botulism.
引用
收藏
页码:9621 / 9627
页数:7
相关论文
共 39 条
  • [1] Structural analysis of botulinum neurotoxin serotype F light chain: Implications on substrate binding and inhibitor design
    Agarwal, R
    Binz, T
    Swaminathan, S
    [J]. BIOCHEMISTRY, 2005, 44 (35) : 11758 - 11765
  • [2] Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzyme
    Agarwal, R
    Binz, T
    Swaminathan, S
    [J]. BIOCHEMISTRY, 2005, 44 (23) : 8291 - 8302
  • [3] Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212→Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway
    Agarwal, R
    Eswaramoorthy, S
    Kumaran, D
    Binz, T
    Swaminathan, S
    [J]. BIOCHEMISTRY, 2004, 43 (21) : 6637 - 6644
  • [4] Enzymatic autocatalysis of botulinum a neurotoxin light chain
    Ahmed, SA
    Byrne, MP
    Jensen, M
    Hines, HB
    Brueggemann, E
    Smith, LA
    [J]. JOURNAL OF PROTEIN CHEMISTRY, 2001, 20 (03): : 221 - 231
  • [5] Crystal structure of botulinum neurotoxin type G light chain: Serotype divergence in substrate recognition
    Arndt, JW
    Yu, W
    Bi, F
    Stevens, RC
    [J]. BIOCHEMISTRY, 2005, 44 (28) : 9574 - 9580
  • [6] ARNON SS, 1978, LANCET, V1, P1273
  • [7] Ascher B, 2004, Ann Chir Plast Esthet, V49, P537, DOI 10.1016/j.anplas.2004.09.002
  • [8] A molecular basis underlying differences in the toxicity of botulinum serotypes A and E
    Bajohrs, M
    Rickman, C
    Binz, T
    Davletov, B
    [J]. EMBO REPORTS, 2004, 5 (11) : 1090 - 1095
  • [9] The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability
    Baldwin, MR
    Bradshaw, M
    Johnson, EA
    Barbieri, JT
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2004, 37 (01) : 187 - 195
  • [10] Expanding use of botulinum toxin
    Bhidayasiri, R
    Truong, DD
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 235 (1-2) : 1 - 9